Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No numbers given for this or any previous quarter.
No indication if revenue was above or below revenue growth projections made byTM.
No indication of gross margins.
Cant remember the last time i felt this confident about Terns potential
Blue day but no numbers will make any increase restrained but target was £3m, with them ahead of expectations, new target could well be alot higher, looks like TM are on fire, first RNS in a long time to get me looking forward to trading at 8am
Great news but would be good to see some numbers, o don’t think they were producing any revenue of note befire?
According to the recent presentation companies like TM are valued at up to x50 revenues then this impressive growth might yet make TM into the jewel of Tern's portfolio, If they are that far ahead then Tern's stake could be worth around £115m if that valuation is spot on
Exciting times again maybe
Talking Medicines reports record revenue bookings and strategic partnerships in Q1 2024
Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, is pleased to note that Talking Medicines Limited ("Talking Medicines"), a company in which Tern currently holds 23.8% of the equity, has announced an update on its Q1 2024 performance, extracts of which are set out below.
Extracts from the Talking Medicines announcement:
"Talking Medicines, a pioneering leader in healthcare intelligence leveraging advanced data science and artificial intelligence, is pleased to announce a strong start to 2024, marked by record revenue bookings and significant advancements in its innovative platform, Talking Medicines Drug-GPT.
In the first quarter of 2024, Talking Medicines achieved significant success with its Talking Medicines Drug-GPT platform, which aims to revolutionise access to intelligence on pharmaceutical medicine brands and disease areas. This innovative technology has garnered substantial interest from leading global healthcare advertising agencies, who recognise its potential to transform strategies for pharmaceutical clients.
Among Talking Medicines' clients are some of the world's most prominent healthcare advertising agency networks, reaffirming the platform's efficacy in providing key insights derived from aggregated patient and healthcare professional conversations. By tapping into previously unseen data, Talking Medicines empowers its clients to drive better strategies and make informed decisions in relation to the pharmaceutical landscape.
Furthermore, Talking Medicines has forged strategic partnerships with both open and closed data communities, solidifying its commitment to expanding access to crucial insights. Notable among these partnerships is the collaboration with data aggregator Socialgist, which enables Talking Medicines to tap into millions of public conversational sites, enriching the Talking Medicines Drug-GPT platform with a wealth of diverse data sources.
Speaking on these achievements, Jo Halliday CEO expressed excitement about the company's trajectory and the transformative impact of Talking Medicines Drug-GPT on the healthcare industry: "We are thrilled by the broad response to Talking Medicines Drug-GPT and our strategic partnerships. This success underscores our dedication to empowering healthcare stakeholders with actionable insights derived from advanced data science and artificial intelligence."
Looking ahead, Talking Medicines remains committed to driving innovation and fostering collaborations that enhance healthcare decision-making through intelligence globally."
Https://talkingmedicines.com/2024/04/the-fusion-of-ai-and-strategy-a-look-through-drug-gpt/
Remember every time we get a tweet to say this has gone live, this is now producing data means its up to $5 a month income per sensor with little costs to generate that $5, should be in a position to move into Wyld very soon as CGT just been paid, fingers crossed its before the market catches on
The tool is intentionally designed to train surgeons in low- and middle-income countries, home to nine out of ten people with vision loss due to the difficulty of accessing eye care.
Published April 5, 2024
BOSTON, MA – April 5, 2024 – Orbis International and FundamentalVR today launched a new immersive virtual reality (VR) training solution intentionally designed for use in low- and middle-income countries, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The tool is built to support students and residents learning to perform surgery to treat cataracts – the world’s leading cause of blindness, despite being treatable with a short operation – ultimately growing the number of skilled care providers and improving outcomes for patients. The tool’s affordability, portability and scalability, combined with its targeted functionality, make it a key advancement in ophthalmic surgical education globally and will accelerate Orbis’s efforts to build strong and sustainable eye care systems around the world.
Orbis, a global nonprofit, teamed up with FundamentalVR, a technology company dedicated to developing VR surgical training solutions, to create this unique tool. It integrates VR, haptic feedback, cloud assessment data, and off-the-shelf hardware to create a solution for cataract surgical training in resource-limited settings. Immersive VR simulation integrated with haptics provides a highly realistic experience for eye-care professionals, who are able to practice each step repeatedly to cement their understanding of both basic and difficult techniques.
“We saw a real need that we could meet. Most existing simulation training tools are expensive, not easily transportable or sourced, and/or train doctors on a surgical method usually only practiced in high-resource areas. Thanks to our partnership with FundamentalVR, we were able to bring a new VR solution to life that makes cataract surgical training accessible no matter where you live.”
Dr. Hunter Cherwek, Orbis Vice President of Clinical Services and Technologies
The training tool enables independent learning through automated performance monitoring and feedback, a particular benefit to medical professionals without access to robust ophthalmic training opportunities. Residents can hone their skills in a realistic simulation, practicing first in a safe environment before entering the operating room, which is proven to yield better surgical outcomes. Users of the platform can supplement their learning with Cybersight, Orbis’s telemedicine and e-learning platform.
“Our partnership with Orbis International not only underscores our commitment to advancing the field of ophthalmology but also highlights the immense potential of VR in creating safer, more effective learning environments for healthcare professionals. Our goal is to elevate patient outcomes and redefine the standard of surgical proficiency on a global scale, advancing the qu
Wyld Networks, a lead provider of sensor-to-satellite connectivity solutions for IoT, is thrilled to announce its participation in Connected North 2024, a premier regional forum dedicated to advancing digital connectivity in the North of the UK. The event is scheduled to be held on April 22nd and 23rd, 2024, at Manchester Central.
Connected North 2024 aims to address the imperative need for enhanced connectivity in the Northern region of the UK, aligning with the government's commitment to making gigabit capable networks accessible for 85% of the country by the end of 2025. Beyond governmental targets, the focus is on enriching lives within local communities, fostering opportunities for regional businesses, and bolstering the global competitiveness of the region. This pivotal event will convene 200 expert speakers and 2,500 attendees from various sectors of the digital economy ecosystem, facilitating discussions on connectivity-driven social and economic growth.
The conference will explore key themes such as strategies for upgrading digital infrastructure, funding mechanisms, and the transformative potential of government policies. It will delve into tailored technology solutions and delivery strategies aimed at overcoming the unique challenges faced in deploying advanced connectivity services across homes and businesses in the region. Additionally, there will be discussions on leveraging digital connectivity to drive efficiency, foster community connections, and bridge the digital divide, thus promoting social and economic growth.
As a leader in IoT solutions, Wyld Networks is committed to driving innovation and excellence in connectivity. Founded in 2016 in Cambridge, United Kingdom, the company has consistently delivered state-of-the-art technology that facilitates seamless communication between sensors and satellite networks. With successful implementations across sectors such as agriculture, energy, utilities, logistics, and environmental projects, Wyld Networks empowers clients to harness the full potential of IoT data, leading to increased operational efficiency and informed decision-making.
"We are excited to showcase our IoT connectivity solutions at Connected North 2024 and engage with both existing partners and prospective customers," commented Eric Hewitson, Head of Communications for Wyld Networks UK.
Wyld Networks invites all interested parties to visit their booth during Connected North 2024 to explore the latest advancements in IoT connectivity. Attendees will have the opportunity to learn how Wyld Networks' innovative products, including Wyld Connect and Wyld Fusion, are shaping the future of digital connectivity in the Northern region.
Wyld Networks
@WyldNetworks
·
7h
Incredible milestone for IMAE - Inovação em Mecânica, Aeronáutica e Energia. The first wind turbine installed in a Telco Tower in Latin America. We are proud to play a part in providing #satelliteIoT connectivity for this amazing project.
#IoTSolutions #SustainableEnergy
The leader board .
and long may it continue . LoL
GLA
Book Price end of 2022 was £24.86m. Current MCAP £11.27m. So I know investments worth has dropped since then but I think Book price is still above MCAP...?
Apologies, 6.4p...
It was 6.9p end of 2022....
No but the SP is still well below NAV? Anyone have end of 2023 NAV figure?
Looks like it is moving this afternoon anyone know why?
Looking to break and hold 2.9p, to close the gap-down on 23rd Jan this year.
Fingers crossed
GLA
H
Wyld Networks' sensor to satellite technology enters the Brazilian market for pollination monitoring through an agreement with GeoApis
Wyld Networks, together with Brazil-based GeoApis, has entered into an agreement to monitor bee colonies using Wyld's low-orbit satellite connection. Wyld Connect will support GeoApis to increase yields and improve sustainability for beekeepers, crop producers and growers to increase agricultural productivity.
Brazil is the third-largest agricultural producer and exporter in the world (Schneider et al., 2021), with about 60% of crops relying on pollinators in some way (Giannini et al., 2015).
In Brazil, the large agricultural areas and lack of rural coverage make it extremely difficult to monitor the health of pollinator populations.
Based in Brazil's Agtech Valley ecosystem in Piracicaba/SP, GeoApis works with over 300 beekeepers and over 4,000 bee colonies.
Specializing in reducing and preventing bee mortality, GeoApis focuses on the relationship between colony management and the use of pesticides and other agricultural ingredients. They protect bees and biodiversity by offering continuous eco-friendly solutions and projects to agricultural companies, agricultural producers and companies interested in sustainability.
With a coverage of over 500,000 hectares, GeoApis monitors more than 1 billion bees with customers in the sugar cane industry Wyld is meeting the challenges of connecting the Internet of Things in Brazil's agricultural sector via low-orbit satellites," said Alastair Williamson, CEO of Wyld Networks. "We are excited to partner with GeoApis on crucial projects that will have a significant impact on pollination and sustainability."
Looks like placing shares being sold
The whole crew back on advfn, pumped and now being dumped.
To go and it’s back to where it was 3 years ago… well done MGMT doing a sterling job.
FundamentalVR CEO and Co-Founder Richard Vincent sat down with John Koetsier at Forbes, speaking on how surgeons are using Apple Vision Pro to improve training efficiency by decreasing skills acquisition time 40% to 100%.
Apple Vision Pro has allowed surgeons to upskill to a level where they can achieve “pre-human competence” all before stepping foot in an OR.
“Our vision is all about getting to something we call pre-human competence, which is don’t practice on me, practice on a simulated version of me and then come into the OR and perform on me.”
https://www.forbes.com/sites/johnkoetsier/2024/03/29/apple-vision-pro-could-reduce-surgeon-training-time-40-to-200/?sh=314bdbb369a2
https://fundamentalsurgery.com/medical-device-news-magazine-apple-vision-pro/
Wyld releasing minor good news of revenues flowing from a previous announcement and down 9%
Tern with around 800k net buys and bid is lower now compared with start bid price
Weird
One that I have and may come good from 2p so now on the right side.